Intellectual Disability and Sepsis: Understanding Disparities and Care Needs

Intellectual Disability and Sepsis: Understanding Disparities and Care Needs

5 (1 vote)

Recorded On: 03/16/2022

Description: 

In this webinar, experts in healthcare delivery, disability, and sepsis discuss the critical need to address health disparities for people with intellectual disabilities and sepsis.

Learning Objectives: 

At the end of the activity, the learner should be able to:

  • Understand what is currently known about health disparities for people with intellectual disability;
  • Describe the reasons why sepsis may be more impactful in this population;
  • Understand the compounding impact of disability and social determinants of health;
  • Understand what is currently known about sepsis care and outcomes for people with intellectual disabilities.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Webinar Supporters:

Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Clinical Community sponsors and the WITH Foundation. 

image

image

Jonathan L. Gleason, MD

Chief Clinical Officer, Executive Vice President

Prisma Health

Dr. Jonathan L. Gleason is a renowned thought leader and healthcare executive. He has served in executive roles at several of America’s most notable clinically integrated health systems – Carilion Clinic, Jefferson Health, and Prisma Health. Dr. Gleason currently serves as executive vice president, Chief Clinical Officer for Prisma Health with broad responsibilities for the clinical and academic mission of the $5bn, 18-hospital clinical integrated health system. His work to build clinical operating systems that are elite partners to people has achieved remarkable results inside of traditional health systems as well as in the business community. Dr. Gleason’s work has been recognized by multiple national awards for innovation in care delivery and safety, and his insights on these topic are in high demand in publications such as the New England Journal, the World Economic Forum and the Wall Street Journal. Dr. Gleason is also a researcher and advocate for people with disabilities and his landmark publication in the New England Journal of Medicine Catalyst about the impact of COVID-19 on individuals with intellectual disabilities resulted in global changes to vaccine prioritization. Dr. Gleason serves on advisory committees for Special Olympics International, and he serves on the board of Special Olympics Pennsylvania.

Cindy Hou DO, MA, MBA, FACOI, FACP, FIDSA

Infection Control Officer

Jefferson Health, New Jersey

Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, is the Infection Control Officer and Medical Director of Research for Jefferson Health - New Jersey (JNJ) and an infectious diseases specialist. She is dually board certified in internal medicine and infectious diseases. Dr. Hou has expertise in sepsis, antibiotic stewardship, and infection control. Dr. Hou is the Chief Medical Officer of  Sepsis Alliance and a member of its board of directors; she is also a medical advisor for the Sepsis Innovation Collaborative. Dr. Hou earned an M.B.A. and M.A. from Boston University, a D.O. from the University of New England College of Osteopathic Medicine, and a BS from Yale University. She has a certification in Infection Prevention and Control (CIC), is a Certified Professional in Healthcare Quality (CPHQ), and a Certified Professional in Patient Safety (CPPS). Dr. Hou is a fellow for the American College of Osteopathic Internists (ACOI), American College of Physicians (ACP) and the Infectious Diseases Society of America (IDSA). 

No relevant financial relationships to disclose.

Wendy Ross, MD, FAAP

Developmental and Behavioral Pediatrician and Director Jefferson Center for Autism and Neurodiversity

Jefferson Health

Wendy J. Ross, MD, FAAP is a developmental and behavioral pediatrician and the inaugural director of the Jefferson Center for Autism and Neurodiversity where she create community opportunities. She was a top ten CNN hero in 2014 for her work on community participation. Dr. Ross attended the humanities and medicine program at Mt Sinai, pediatrics residency at Yale, and fellowship in developmental pediatrics at Harvard. 

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.

Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Components visible upon registration.